pharma is the sole category represented across all 1 tracked stories. Of the tracked stories, 1 of 1 also mention Aeterna Zentaris GmbH, the most common co-covered peer. Wuzhou Drug International Trading Limited appears in 1 tracked Biotech story from March 6, 2026.
Recent coverage · Wuzhou Drug International Trading Limited
1story
avg impact
0%positive
0%negative
100% neutral
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Wuzhou Drug International Trading Limited
pharma is the sole category represented across all 1 tracked stories. Of the tracked stories, 1 of 1 also mention Aeterna Zentaris GmbH, the most common co-covered peer. Wuzhou Drug International Trading Limited appears in 1 tracked Biotech story from March 6, 2026. The tracked stories average 2 original sources each.
Stories tracked
1
Sources per story
2
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 18 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Wuzhou Drug International Trading Limited. Shared-story counts are live from our verified record — not editorial picks.
COSCIENS Biopharma Inc. has announced a definitive strategic shift by ceasing all funding for its German subsidiaries, Aeterna Zentaris GmbH and Zentaris IVF GmbH. The decision triggers a structured insolvency process for the units following the failure of a Phase 3 pediatric trial for its flagship diagnostic, Macrilen.
Wuzhou Drug International Trading Limited is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source
link? Report a data issue.